25 XP   0   0   10

Suparma Tbk
Buy, Hold or Sell?

Let's analyse Suparma Tbk together

PenkeI guess you are interested in Suparma Tbk. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Suparma Tbk. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Suparma Tbk

I send you an email if I find something interesting about Suparma Tbk.

Quick analysis of Suparma Tbk (30 sec.)










What can you expect buying and holding a share of Suparma Tbk? (30 sec.)

How much money do you get?

How much money do you get?
Rp0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
Rp680.48
Expected worth in 1 year
Rp1,100.01
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
Rp419.54
Return On Investment
129.5%

For what price can you sell your share?

Current Price per Share
Rp324.00
Expected price per share
Rp0 - Rp332.00
How sure are you?
50%

1. Valuation of Suparma Tbk (5 min.)




Live pricePrice per Share (EOD)

Rp324.00

Intrinsic Value Per Share

Rp1,649.34 - Rp6,204.16

Total Value Per Share

Rp2,329.82 - Rp6,884.64

2. Growth of Suparma Tbk (5 min.)




Is Suparma Tbk growing?

Current yearPrevious yearGrowGrow %
How rich?$214.6m$181.5m$33m15.4%

How much money is Suparma Tbk making?

Current yearPrevious yearGrowGrow %
Making money$33.6m$29.4m$4.1m12.4%
Net Profit Margin10.7%10.5%--

How much money comes from the company's main activities?

3. Financial Health of Suparma Tbk (5 min.)




4. Comparing to competitors in the Paper & Paper Products industry (5 min.)




  Industry Rankings (Paper & Paper Products)  


Richest
#62 / 120

Most Revenue
#46 / 120

Most Profit
#25 / 120

What can you expect buying and holding a share of Suparma Tbk? (5 min.)

Welcome investor! Suparma Tbk's management wants to use your money to grow the business. In return you get a share of Suparma Tbk.

What can you expect buying and holding a share of Suparma Tbk?

First you should know what it really means to hold a share of Suparma Tbk. And how you can make/lose money.

Speculation

The Price per Share of Suparma Tbk is Rp324.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Suparma Tbk.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Suparma Tbk, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp680.48. Based on the TTM, the Book Value Change Per Share is Rp104.88 per quarter. Based on the YOY, the Book Value Change Per Share is Rp90.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Suparma Tbk.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps0.010.0%0.010.0%0.010.0%0.010.0%0.000.0%
Usd Book Value Change Per Share0.010.0%0.010.0%0.010.0%0.010.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.010.0%0.010.0%0.010.0%0.000.0%
Usd Price Per Share0.05-0.05-0.07-0.04-0.03-
Price to Earnings Ratio4.65-4.65-7.50-7.15-5.57-
Price-to-Total Gains Ratio4.73-4.73-6.99-6.13-1.85-
Price to Book Ratio0.73-0.73-1.22-0.79-0.72-
Price-to-Total Gains Ratio4.73-4.73-6.99-6.13-1.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0324
Number of shares30864
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (30864 shares)323.71215.40
Gains per Year (30864 shares)1,294.86861.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101295128599763852
202590258019815251714
303885387529722882576
405179517039630503438
506474646549538134300
607769776059445755162
709064905569353386024
80103591035079261006886
90116541164589168637748
100129491294099176258610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.01.01.080.0%16.01.06.069.6%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%17.06.00.073.9%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%4.00.06.040.0%5.00.018.021.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%17.06.00.073.9%

Fundamentals of Suparma Tbk

About Suparma Tbk

PT Suparma Tbk manufactures and sells paper and related paper products in Indonesia. Its paper products include laminated wrapping and brown Kraft, and sandwiched ribbed Kraft recycle papers; white papers; and carton papers. The company also provides bathroom, facial, napkin, and carrier tissues; hand, hand roll, industrial and clinical roll, and kitchen towels; and OEM products. In addition, it engages in exporting activities. The company was formerly known as PT Supar Inpama and changed its name to PT Suparma Tbk in December 1978. PT Suparma Tbk was founded in 1976 and is headquartered in Surabaya, Indonesia.

Fundamental data was last updated by Penke on 2024-04-03 19:13:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Suparma Tbk.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Suparma Tbk earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compare Suparma Tbk to the Paper & Paper Products industry mean.
  • A Net Profit Margin of 10.7% means that Rp0.11 for each Rp1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Suparma Tbk:

  • The MRQ is 10.7%. The company is making a huge profit. +2
  • The TTM is 10.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.7%TTM10.7%0.0%
TTM10.7%YOY10.5%+0.2%
TTM10.7%5Y7.4%+3.3%
5Y7.4%10Y4.6%+2.8%
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ10.7%2.6%+8.1%
TTM10.7%3.5%+7.2%
YOY10.5%5.9%+4.6%
5Y7.4%4.8%+2.6%
10Y4.6%4.5%+0.1%
1.1.2. Return on Assets

Shows how efficient Suparma Tbk is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Suparma Tbk to the Paper & Paper Products industry mean.
  • 10.4% Return on Assets means that Suparma Tbk generated Rp0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Suparma Tbk:

  • The MRQ is 10.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.4%TTM10.4%0.0%
TTM10.4%YOY10.7%-0.3%
TTM10.4%5Y7.3%+3.0%
5Y7.3%10Y4.5%+2.8%
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4%0.9%+9.5%
TTM10.4%1.1%+9.3%
YOY10.7%2.2%+8.5%
5Y7.3%1.5%+5.8%
10Y4.5%1.4%+3.1%
1.1.3. Return on Equity

Shows how efficient Suparma Tbk is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Suparma Tbk to the Paper & Paper Products industry mean.
  • 15.7% Return on Equity means Suparma Tbk generated Rp0.16 for each Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Suparma Tbk:

  • The MRQ is 15.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 15.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.7%TTM15.7%0.0%
TTM15.7%YOY16.2%-0.6%
TTM15.7%5Y11.5%+4.1%
5Y11.5%10Y7.3%+4.2%
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ15.7%1.9%+13.8%
TTM15.7%2.1%+13.6%
YOY16.2%4.3%+11.9%
5Y11.5%2.7%+8.8%
10Y7.3%2.9%+4.4%

1.2. Operating Efficiency of Suparma Tbk.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Suparma Tbk is operating .

  • Measures how much profit Suparma Tbk makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Suparma Tbk to the Paper & Paper Products industry mean.
  • An Operating Margin of 0.0% means the company generated Rp0.00  for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Suparma Tbk:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY14.6%-14.6%
TTM-5Y8.3%-8.3%
5Y8.3%10Y6.6%+1.7%
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.4%-7.4%
TTM-3.5%-3.5%
YOY14.6%7.6%+7.0%
5Y8.3%7.1%+1.2%
10Y6.6%6.7%-0.1%
1.2.2. Operating Ratio

Measures how efficient Suparma Tbk is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Paper & Paper Products industry mean).
  • An Operation Ratio of 1.60 means that the operating costs are Rp1.60 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Suparma Tbk:

  • The MRQ is 1.603. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.603. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.603TTM1.6030.000
TTM1.603YOY1.643-0.040
TTM1.6035Y1.513+0.090
5Y1.51310Y1.441+0.072
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6031.550+0.053
TTM1.6031.521+0.082
YOY1.6431.252+0.391
5Y1.5131.306+0.207
10Y1.4411.199+0.242

1.3. Liquidity of Suparma Tbk.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Suparma Tbk is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Paper & Paper Products industry mean).
  • A Current Ratio of 3.65 means the company has Rp3.65 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Suparma Tbk:

  • The MRQ is 3.655. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.655. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.655TTM3.6550.000
TTM3.655YOY2.228+1.427
TTM3.6555Y2.599+1.055
5Y2.59910Y1.741+0.858
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6551.648+2.007
TTM3.6551.550+2.105
YOY2.2281.537+0.691
5Y2.5991.539+1.060
10Y1.7411.358+0.383
1.3.2. Quick Ratio

Measures if Suparma Tbk is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Suparma Tbk to the Paper & Paper Products industry mean.
  • A Quick Ratio of 1.44 means the company can pay off Rp1.44 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Suparma Tbk:

  • The MRQ is 1.436. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.436. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.436TTM1.4360.000
TTM1.436YOY0.908+0.528
TTM1.4365Y1.054+0.381
5Y1.05410Y0.815+0.240
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4360.666+0.770
TTM1.4360.657+0.779
YOY0.9080.802+0.106
5Y1.0540.729+0.325
10Y0.8150.659+0.156

1.4. Solvency of Suparma Tbk.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Suparma Tbk assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Suparma Tbk to Paper & Paper Products industry mean.
  • A Debt to Asset Ratio of 0.34 means that Suparma Tbk assets are financed with 33.7% credit (debt) and the remaining percentage (100% - 33.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Suparma Tbk:

  • The MRQ is 0.337. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.337. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.337TTM0.3370.000
TTM0.337YOY0.339-0.001
TTM0.3375Y0.377-0.040
5Y0.37710Y0.469-0.092
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3370.475-0.138
TTM0.3370.468-0.131
YOY0.3390.480-0.141
5Y0.3770.487-0.110
10Y0.4690.516-0.047
1.4.2. Debt to Equity Ratio

Measures if Suparma Tbk is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Suparma Tbk to the Paper & Paper Products industry mean.
  • A Debt to Equity ratio of 50.9% means that company has Rp0.51 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Suparma Tbk:

  • The MRQ is 0.509. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.509. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.509TTM0.5090.000
TTM0.509YOY0.513-0.003
TTM0.5095Y0.615-0.106
5Y0.61510Y0.977-0.362
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5090.911-0.402
TTM0.5090.876-0.367
YOY0.5130.922-0.409
5Y0.6150.980-0.365
10Y0.9771.166-0.189

2. Market Valuation of Suparma Tbk

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every Rp1 in earnings Suparma Tbk generates.

  • Above 15 is considered overpriced but always compare Suparma Tbk to the Paper & Paper Products industry mean.
  • A PE ratio of 4.65 means the investor is paying Rp4.65 for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Suparma Tbk:

  • The EOD is 3.040. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.654. Based on the earnings, the company is cheap. +2
  • The TTM is 4.654. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.040MRQ4.654-1.614
MRQ4.654TTM4.6540.000
TTM4.654YOY7.501-2.847
TTM4.6545Y7.145-2.491
5Y7.14510Y5.568+1.577
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
EOD3.0405.628-2.588
MRQ4.6545.407-0.753
TTM4.6545.203-0.549
YOY7.5018.355-0.854
5Y7.1458.187-1.042
10Y5.56810.907-5.339
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Suparma Tbk:

  • The EOD is 1.185. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.815. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.815. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.185MRQ1.815-0.629
MRQ1.815TTM1.8150.000
TTM1.815YOY2.964-1.150
TTM1.8155Y-8.573+10.387
5Y-8.57310Y-0.664-7.909
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
EOD1.1853.681-2.496
MRQ1.8153.338-1.523
TTM1.8153.388-1.573
YOY2.9642.943+0.021
5Y-8.5734.032-12.605
10Y-0.6643.523-4.187
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Suparma Tbk is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Paper & Paper Products industry mean).
  • A PB ratio of 0.73 means the investor is paying Rp0.73 for each Rp1 in book value.

Let's take a look of the Price to Book Ratio trends of Suparma Tbk:

  • The EOD is 0.476. Based on the equity, the company is cheap. +2
  • The MRQ is 0.729. Based on the equity, the company is cheap. +2
  • The TTM is 0.729. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.476MRQ0.729-0.253
MRQ0.729TTM0.7290.000
TTM0.729YOY1.216-0.487
TTM0.7295Y0.794-0.065
5Y0.79410Y0.719+0.075
Compared to industry (Paper & Paper Products)
PeriodCompanyIndustry (mean)+/- 
EOD0.4760.993-0.517
MRQ0.7290.926-0.197
TTM0.7290.941-0.212
YOY1.2161.109+0.107
5Y0.7941.122-0.328
10Y0.7191.267-0.548
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Suparma Tbk compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--104.884104.8840%90.068+16%61.767+70%43.334+142%
Book Value Per Share--680.477680.4770%575.593+18%515.223+32%402.317+69%
Current Ratio--3.6553.6550%2.228+64%2.599+41%1.741+110%
Debt To Asset Ratio--0.3370.3370%0.3390%0.377-10%0.469-28%
Debt To Equity Ratio--0.5090.5090%0.513-1%0.615-17%0.977-48%
Dividend Per Share----0%10.029-100%8.023-100%4.012-100%
Eps--106.572106.5720%93.316+14%63.805+67%37.589+184%
Free Cash Flow Per Share--273.344273.3440%236.128+16%152.228+80%85.751+219%
Free Cash Flow To Equity Per Share--34.00434.0040%31.769+7%1.196+2743%4.539+649%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max--6204.159--------
Intrinsic Value_10Y_min--1649.340--------
Intrinsic Value_1Y_max--321.029--------
Intrinsic Value_1Y_min--106.885--------
Intrinsic Value_3Y_max--1193.708--------
Intrinsic Value_3Y_min--373.622--------
Intrinsic Value_5Y_max--2342.656--------
Intrinsic Value_5Y_min--695.827--------
Market Cap1021925154816.000-53%1564429741120.0001564429741120.0000%2207862988800.000-29%1317148199129.600+19%947488742099.200+65%
Net Profit Margin--0.1070.1070%0.105+2%0.074+45%0.046+132%
Operating Margin----0%0.146-100%0.083-100%0.066-100%
Operating Ratio--1.6031.6030%1.643-2%1.513+6%1.441+11%
Pb Ratio0.476-53%0.7290.7290%1.216-40%0.794-8%0.719+1%
Pe Ratio3.040-53%4.6544.6540%7.501-38%7.145-35%5.568-16%
Price Per Share324.000-53%496.000496.0000%700.000-29%417.600+19%300.400+65%
Price To Free Cash Flow Ratio1.185-53%1.8151.8150%2.964-39%-8.573+572%-0.664+137%
Price To Total Gains Ratio3.089-53%4.7294.7290%6.993-32%6.134-23%1.849+156%
Quick Ratio--1.4361.4360%0.908+58%1.054+36%0.815+76%
Return On Assets--0.1040.1040%0.107-3%0.073+41%0.045+130%
Return On Equity--0.1570.1570%0.162-3%0.115+36%0.073+113%
Total Gains Per Share--104.884104.8840%100.097+5%69.790+50%47.346+122%
Usd Book Value--214628827.479214628827.4790%181547334.485+18%162506039.004+32%126894555.816+69%
Usd Book Value Change Per Share--0.0100.0100%0.009+16%0.006+70%0.004+142%
Usd Book Value Per Share--0.0680.0680%0.058+18%0.052+32%0.040+69%
Usd Dividend Per Share----0%0.001-100%0.001-100%0.000-100%
Usd Eps--0.0110.0110%0.009+14%0.006+67%0.004+184%
Usd Free Cash Flow--86215309.85886215309.8580%74476996.744+16%48014044.213+80%27046733.871+219%
Usd Free Cash Flow Per Share--0.0270.0270%0.024+16%0.015+80%0.009+219%
Usd Free Cash Flow To Equity Per Share--0.0030.0030%0.003+7%0.000+2743%0.000+649%
Usd Market Cap102192515.482-53%156442974.112156442974.1120%220786298.880-29%131714819.913+19%94748874.210+65%
Usd Price Per Share0.032-53%0.0500.0500%0.070-29%0.042+19%0.030+65%
Usd Profit--33613834.94933613834.9490%29432556.005+14%19893213.552+69%11740096.044+186%
Usd Revenue--313805409.485313805409.4850%279445267.185+12%259748641.624+21%215811699.209+45%
Usd Total Gains Per Share--0.0100.0100%0.010+5%0.007+50%0.005+122%
 EOD+4 -4MRQTTM+0 -0YOY+26 -95Y+28 -710Y+29 -7

3.2. Fundamental Score

Let's check the fundamental score of Suparma Tbk based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-153.040
Price to Book Ratio (EOD)Between0-10.476
Net Profit Margin (MRQ)Greater than00.107
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.436
Current Ratio (MRQ)Greater than13.655
Debt to Asset Ratio (MRQ)Less than10.337
Debt to Equity Ratio (MRQ)Less than10.509
Return on Equity (MRQ)Greater than0.150.157
Return on Assets (MRQ)Greater than0.050.104
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Suparma Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.321
Ma 20Greater thanMa 50343.400
Ma 50Greater thanMa 100348.720
Ma 100Greater thanMa 200354.620
OpenGreater thanClose330.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in IDR. All numbers in thousands.

Summary
Total Assets3,239,231,500
Total Liabilities1,092,943,225
Total Stockholder Equity2,146,288,275
 As reported
Total Liabilities 1,092,943,225
Total Stockholder Equity+ 2,146,288,275
Total Assets = 3,239,231,500

Assets

Total Assets3,239,231,500
Total Current Assets1,370,508,318
Long-term Assets1,868,723,182
Total Current Assets
Cash And Cash Equivalents 300,142,974
Short-term Investments 13,719,171
Net Receivables 210,851,214
Inventory 832,474,709
Total Current Assets  (as reported)1,370,508,318
Total Current Assets  (calculated)1,357,188,068
+/- 13,320,250
Long-term Assets
Property Plant Equipment 1,829,176,330
Intangible Assets 275,870,000
Long-term Assets  (as reported)1,868,723,182
Long-term Assets  (calculated)2,105,046,330
+/- 236,323,148

Liabilities & Shareholders' Equity

Total Current Liabilities374,992,625
Long-term Liabilities717,950,600
Total Stockholder Equity2,146,288,275
Total Current Liabilities
Short-term Debt 32,031,790
Short Long Term Debt 157,879,790
Accounts payable 132,685,791
Total Current Liabilities  (as reported)374,992,625
Total Current Liabilities  (calculated)322,597,370
+/- 52,395,255
Long-term Liabilities
Long term Debt Total 512,460,392
Capital Lease Obligations 80,980,913
Long-term Liabilities Other 5,136,586
Long-term Liabilities  (as reported)717,950,600
Long-term Liabilities  (calculated)598,577,891
+/- 119,372,709
Total Stockholder Equity
Common Stock1,261,636,886
Retained Earnings 881,406,576
Capital Surplus 4,319,905
Other Stockholders Equity -1,075,093
Total Stockholder Equity (as reported)2,146,288,275
Total Stockholder Equity (calculated)2,146,288,275
+/-0
Other
Capital Stock1,261,636,886
Cash and Short Term Investments 313,862,144
Common Stock Shares Outstanding 3,154,092
Liabilities and Stockholders Equity 3,239,231,500
Net Debt 349,195,519
Net Invested Capital 2,795,626,768
Net Working Capital 995,515,693
Property Plant and Equipment Gross 3,490,624,032



Balance Sheet

Currency in IDR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
976,351,000
1,036,685,000
1,043,262,637
1,031,826,785
1,085,460,878
1,320,218,592
1,381,433,819
1,501,891,919
1,564,901,726
1,432,637,490
1,490,033,771
1,551,777,407
1,664,353,265
1,767,105,819
2,091,957,079
2,185,464,366
2,158,852,416
2,175,660,855
2,282,845,633
2,372,130,751
2,316,065,006
2,746,153,295
3,239,231,500
3,239,231,5002,746,153,2952,316,065,0062,372,130,7512,282,845,6332,175,660,8552,158,852,4162,185,464,3662,091,957,0791,767,105,8191,664,353,2651,551,777,4071,490,033,7711,432,637,4901,564,901,7261,501,891,9191,381,433,8191,320,218,5921,085,460,8781,031,826,7851,043,262,6371,036,685,000976,351,000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
712,695,266
699,313,460
750,237,084
887,986,684
916,211,954
645,476,168
1,004,400,966
1,370,508,318
1,370,508,3181,004,400,966645,476,168916,211,954887,986,684750,237,084699,313,460712,695,266000000000000000
       Cash And Cash Equivalents 
6,114,000
3,269,000
2,573,598
11,084,621
4,533,291
2,177,328
3,471,601
5,550,451
7,683,217
7,392,756
6,332,321
29,713,402
40,594,633
20,287,265
47,925,923
46,258,913
146,960,519
120,542,709
240,382,044
207,414,748
111,724,002
197,491,630
300,142,974
300,142,974197,491,630111,724,002207,414,748240,382,044120,542,709146,960,51946,258,91347,925,92320,287,26540,594,63329,713,4026,332,3217,392,7567,683,2175,550,4513,471,6012,177,3284,533,29111,084,6212,573,5983,269,0006,114,000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,719,171
13,719,1710000000000000000000000
       Net Receivables 
51,989,000
122,960,000
111,865,836
76,691,015
74,325,972
57,342,488
85,126,638
115,295,560
140,491,590
129,638,321
144,787,889
183,853,014
184,117,267
195,976,402
181,435,555
153,716,230
108,132,846
112,110,911
127,405,157
183,126,549
141,687,307
211,808,670
210,851,214
210,851,214211,808,670141,687,307183,126,549127,405,157112,110,911108,132,846153,716,230181,435,555195,976,402184,117,267183,853,014144,787,889129,638,321140,491,590115,295,56085,126,63857,342,48874,325,97276,691,015111,865,836122,960,00051,989,000
       Other Current Assets 
10,184,000
9,810,000
5,664,263
7,330,870
10,552,086
2,424,945
6,547,172
5,911,199
5,147,379
11,343,017
13,247,494
10,811,332
8,268,350
27,514,632
65,460,957
31,265,672
35,265,460
33,438,874
42,882,053
57,217,408
21,292,781
10,361,827
0
010,361,82721,292,78157,217,40842,882,05333,438,87435,265,46031,265,67265,460,95727,514,6328,268,35010,811,33213,247,49411,343,0175,147,3795,911,1996,547,1722,424,94510,552,0867,330,8705,664,2639,810,00010,184,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,670,588,838
1,741,752,329
1,868,723,182
1,868,723,1821,741,752,3291,670,588,83800000000000000000000
       Property Plant Equipment 
721,587,000
712,753,000
713,111,061
712,429,356
731,831,633
971,151,350
1,010,512,985
1,055,582,683
915,335,691
1,037,308,666
1,137,942,520
1,172,989,828
1,173,192,700
1,201,431,103
1,389,719,740
1,439,722,059
1,430,164,650
1,393,421,919
1,367,186,114
1,438,907,504
1,395,391,494
1,445,065,106
1,829,176,330
1,829,176,3301,445,065,1061,395,391,4941,438,907,5041,367,186,1141,393,421,9191,430,164,6501,439,722,0591,389,719,7401,201,431,1031,173,192,7001,172,989,8281,137,942,5201,037,308,666915,335,6911,055,582,6831,010,512,985971,151,350731,831,633712,429,356713,111,061712,753,000721,587,000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,256,308
7,251,274
9,477,244
9,461,262
0
0
0
0
00009,461,2629,477,2447,251,2745,256,308000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
157,244,000
0
0
0
0
0
0
0
0
0
0
0
263,752,057
266,923,700
275,870,000
275,870,000266,923,700263,752,05700000000000157,244,00000000000
> Total Liabilities 
647,455,000
768,708,000
832,711,214
810,049,604
915,545,438
914,652,927
932,696,561
825,757,412
903,069,442
743,872,732
771,648,179
800,315,824
884,860,701
1,011,571,249
1,287,357,024
1,432,787,246
1,079,705,865
1,003,465,520
1,028,235,954
994,592,157
784,672,949
930,679,950
1,092,943,225
1,092,943,225930,679,950784,672,949994,592,1571,028,235,9541,003,465,5201,079,705,8651,432,787,2461,287,357,0241,011,571,249884,860,701800,315,824771,648,179743,872,732903,069,442825,757,412932,696,561914,652,927915,545,438810,049,604832,711,214768,708,000647,455,000
   > Total Current Liabilities 
826,308,000
947,561,000
832,711,214
66,747,575
43,405,997
305,133,958
73,442,832
90,239,449
136,022,510
251,560,663
90,034,510
304,846,562
182,354,489
456,536,668
186,961,154
765,797,691
283,923,795
733,771,730
236,077,149
565,569,011
372,561,062
450,774,755
374,992,625
374,992,625450,774,755372,561,062565,569,011236,077,149733,771,730283,923,795765,797,691186,961,154456,536,668182,354,489304,846,56290,034,510251,560,663136,022,51090,239,44973,442,832305,133,95843,405,99766,747,575832,711,214947,561,000826,308,000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,600,822
127,090,037
130,329,393
128,852,408
20,118,516
83,435,895
67,868,285
32,031,790
32,031,79067,868,28583,435,89520,118,516128,852,408130,329,393127,090,037103,600,822000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
557,336,611
45,129,427
521,074,172
14,876,392
0
224,485,895
254,609,327
157,879,790
157,879,790254,609,327224,485,895014,876,392521,074,17245,129,427557,336,611000000000000000
       Accounts payable 
7,006,000
8,445,000
10,954,307
7,766,897
8,388,012
15,984,339
29,495,574
35,229,403
48,902,653
22,572,876
26,465,590
38,459,608
34,097,175
37,218,170
38,705,967
36,970,095
47,510,128
62,025,368
75,032,912
78,801,593
103,324,532
104,618,884
132,685,791
132,685,791104,618,884103,324,53278,801,59375,032,91262,025,36847,510,12836,970,09538,705,96737,218,17034,097,17538,459,60826,465,59022,572,87648,902,65335,229,40329,495,57415,984,3398,388,0127,766,89710,954,3078,445,0007,006,000
       Other Current Liabilities 
0
147,565,000
132,908,859
20,957,913
17,831,485
14,131,559
36,248,363
46,025,959
67,382,700
24,079,212
18,613,920
23,396,373
20,181,169
29,624,813
27,409,201
3,914,609
1,981,023
2,931,314
3,180,522
7,946,846
8,584,399
3,886,247
0
03,886,2478,584,3997,946,8463,180,5222,931,3141,981,0233,914,60927,409,20129,624,81320,181,16923,396,37318,613,92024,079,21267,382,70046,025,95936,248,36314,131,55917,831,48520,957,913132,908,859147,565,0000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
412,111,887
479,905,196
717,950,600
717,950,600479,905,196412,111,88700000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
597,372,297
740,159,614
187,132,127
696,197,442
285,543,091
251,758,985
308,503,670
512,460,392
512,460,392308,503,670251,758,985285,543,091696,197,442187,132,127740,159,614597,372,297000000000000000
       Other Liabilities 
0
0
0
78,490,991
1,833,174
3,133,201
5,176,638
5,920,477
8,051,880
10,018,184
12,257,726
15,112,988
17,498,044
18,640,500
20,646,226
33,882,818
55,622,455
82,561,663
95,961,363
143,480,055
160,352,902
171,401,526
0
0171,401,526160,352,902143,480,05595,961,36382,561,66355,622,45533,882,81820,646,22618,640,50017,498,04415,112,98812,257,72610,018,1848,051,8805,920,4775,176,6383,133,2011,833,17478,490,991000
> Total Stockholder Equity
328,896,000
267,977,000
210,551,423
221,777,181
169,915,440
405,565,665
448,737,258
676,134,507
661,832,284
688,764,759
718,385,593
751,461,583
779,492,563
755,534,570
804,600,055
752,677,120
1,079,146,551
1,172,195,335
1,254,609,679
1,377,538,594
1,531,392,058
1,815,473,345
2,146,288,275
2,146,288,2751,815,473,3451,531,392,0581,377,538,5941,254,609,6791,172,195,3351,079,146,551752,677,120804,600,055755,534,570779,492,563751,461,583718,385,593688,764,759661,832,284676,134,507448,737,258405,565,665169,915,440221,777,181210,551,423267,977,000328,896,000
   Common Stock
496,023,000
496,023,000
496,023,329
496,023,329
496,023,329
396,818,663
396,818,663
596,818,663
596,818,663
596,818,663
596,818,663
596,818,663
596,818,663
596,818,663
596,818,663
596,818,663
845,828,383
845,828,383
845,828,383
845,828,383
845,828,383
1,116,493,279
1,261,636,886
1,261,636,8861,116,493,279845,828,383845,828,383845,828,383845,828,383845,828,383596,818,663596,818,663596,818,663596,818,663596,818,663596,818,663596,818,663596,818,663596,818,663396,818,663396,818,663496,023,329496,023,329496,023,329496,023,000496,023,000
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
597,820
597,820
597,820
597,820
597,820
597,820
149,463,512
4,319,905
4,319,905149,463,512597,820597,820597,820597,820597,820597,820000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-153,423
219,970
764,887
166,636
-19,755
-134,376
-117,594
-1,075,093
-1,075,093-117,594-134,376-19,755166,636764,887219,970-153,423000000000000000



Balance Sheet

Currency in IDR. All numbers in thousands.




Cash Flow

Currency in IDR. All numbers in thousands.




Income Statement

Currency in IDR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,732,350,016
Cost of Revenue-2,185,779,092
Gross Profit546,570,924546,570,924
 
Operating Income (+$)
Gross Profit546,570,924
Operating Expense-2,391,058,282
Operating Income341,291,734-1,844,487,358
 
Operating Expense (+$)
Research Development-
Selling General Administrative122,822,421
Selling And Marketing Expenses-
Operating Expense2,391,058,282122,822,421
 
Net Interest Income (+$)
Interest Income5,822,533
Interest Expense-32,535,944
Other Finance Cost-3,608,982
Net Interest Income-30,322,393
 
Pretax Income (+$)
Operating Income341,291,734
Net Interest Income-30,322,393
Other Non-Operating Income Expenses-
Income Before Tax (EBT)299,335,953341,291,734
EBIT - interestExpense = -32,535,944
233,426,461
265,962,405
Interest Expense32,535,944
Earnings Before Interest and Taxes (EBIT)-331,871,897
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax299,335,953
Tax Provision-65,909,492
Net Income From Continuing Ops233,426,461233,426,461
Net Income233,426,461
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-30,322,393
 

Technical Analysis of Suparma Tbk
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Suparma Tbk. The general trend of Suparma Tbk is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Suparma Tbk's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Suparma Tbk.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 328.00 < 330.00 < 332.00.

The bearish price targets are: .

Tweet this
Suparma Tbk Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Suparma Tbk. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Suparma Tbk Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Suparma Tbk. The current macd is -5.34389985.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Suparma Tbk price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Suparma Tbk. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Suparma Tbk price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Suparma Tbk Daily Moving Average Convergence/Divergence (MACD) ChartSuparma Tbk Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Suparma Tbk. The current adx is 24.79.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Suparma Tbk shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Suparma Tbk Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Suparma Tbk. The current sar is 356.55.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Suparma Tbk Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Suparma Tbk. The current rsi is 26.32. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Suparma Tbk Daily Relative Strength Index (RSI) ChartSuparma Tbk Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Suparma Tbk. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Suparma Tbk price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Suparma Tbk Daily Stochastic Oscillator ChartSuparma Tbk Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Suparma Tbk. The current cci is -202.51716247.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Suparma Tbk Daily Commodity Channel Index (CCI) ChartSuparma Tbk Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Suparma Tbk. The current cmo is -60.87154746.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Suparma Tbk Daily Chande Momentum Oscillator (CMO) ChartSuparma Tbk Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Suparma Tbk. The current willr is -92.85714286.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Suparma Tbk Daily Williams %R ChartSuparma Tbk Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Suparma Tbk.

Suparma Tbk Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Suparma Tbk. The current atr is 9.78145556.

Suparma Tbk Daily Average True Range (ATR) ChartSuparma Tbk Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Suparma Tbk. The current obv is -59,968,141.

Suparma Tbk Daily On-Balance Volume (OBV) ChartSuparma Tbk Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Suparma Tbk. The current mfi is 16.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Suparma Tbk Daily Money Flow Index (MFI) ChartSuparma Tbk Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Suparma Tbk.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Suparma Tbk Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Suparma Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.321
Ma 20Greater thanMa 50343.400
Ma 50Greater thanMa 100348.720
Ma 100Greater thanMa 200354.620
OpenGreater thanClose330.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Suparma Tbk with someone you think should read this too:
  • Are you bullish or bearish on Suparma Tbk? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Suparma Tbk? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Suparma Tbk

I send you an email if I find something interesting about Suparma Tbk.


Comments

How you think about this?

Leave a comment

Stay informed about Suparma Tbk.

Receive notifications about Suparma Tbk in your mailbox!